Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. [electronic resource]
Producer: 20050307Description: 3012-20 p. digitalISSN:- 0931-0509
- Animals
- Antihypertensive Agents -- therapeutic use
- Benzimidazoles -- therapeutic use
- Biphenyl Compounds
- Blood Glucose -- metabolism
- Body Weight
- DNA Primers
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Nephropathies -- pathology
- Disease Models, Animal
- Glomerular Mesangium -- pathology
- Glycation End Products, Advanced -- metabolism
- Mice
- Mice, Inbred BALB C
- Mice, Inbred Strains
- Nitric Oxide Synthase -- genetics
- Nitric Oxide Synthase Type II
- Nitric Oxide Synthase Type III
- Oxidative Stress -- drug effects
- Reference Values
- Reverse Transcriptase Polymerase Chain Reaction
- Tetrazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.